BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8360790)

  • 21. The effect of chlorothiazide on bone-related biochemical variables in normal post-menopausal women.
    Peh CA; Horowitz M; Wishart JM; Need AG; Morris HA; Nordin BE
    J Am Geriatr Soc; 1993 May; 41(5):513-6. PubMed ID: 8486884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dose and timing of calcium supplementation on bone resorption in early menopausal women.
    Scopacasa F; Need AG; Horowitz M; Wishart JM; Morris HA; Nordin BE
    Horm Metab Res; 2002 Jan; 34(1):44-7. PubMed ID: 11833002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary calcium, sodium, and bone mass of young females.
    Matkovic V; Ilich JZ; Andon MB; Hsieh LC; Tzagournis MA; Lagger BJ; Goel PK
    Am J Clin Nutr; 1995 Aug; 62(2):417-25. PubMed ID: 7625351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interrelationships between urinary sodium, calcium, hydroxyproline and serum PTH in healthy subjects.
    Chan EL; Ho CS; MacDonald D; Ho SC; Chan TY; Swaminathan R
    Acta Endocrinol (Copenh); 1992 Sep; 127(3):242-5. PubMed ID: 1414150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of estrogen (Premarin) replacement therapy on serum level of total estrogen and urinary excretion of calcium and hydroxyproline in postmenopausal Chinese women.
    Ouyang PC; Chow SN; Huang SC; Hsieh CY
    Proc Natl Sci Counc Repub China B; 1986 Jul; 10(3):162-6. PubMed ID: 3022320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of calcium supplementation on urinary hydroxyproline in osteoporotic postmenopausal women.
    Horowitz M; Need AG; Philcox JC; Nordin BE
    Am J Clin Nutr; 1984 Jun; 39(6):857-9. PubMed ID: 6720619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of dietary sodium intake on urinary calcium excretion in selected Irish individuals.
    Shortt C; Madden A; Flynn A; Morrissey PA
    Eur J Clin Nutr; 1988 Jul; 42(7):595-603. PubMed ID: 3224603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women.
    Need AG; Philcox JC; Hartley TF; Nordin BE
    Aust N Z J Med; 1986 Jun; 16(3):341-6. PubMed ID: 3465310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion.
    Frassetto LA; Nash E; Morris RC; Sebastian A
    Kidney Int; 2000 Aug; 58(2):748-52. PubMed ID: 10916098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical variables in pre- and postmenopausal women: reconciling the calcium and estrogen hypotheses.
    Nordin BE; Need AG; Morris HA; Horowitz M
    Osteoporos Int; 1999; 9(4):351-7. PubMed ID: 10550453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 7-week reduction in salt intake does not contribute to markers of bone metabolism in young healthy subjects.
    Natri AM; Kärkkäinen MU; Ruusunen M; Puolanne E; Lamberg-Allardt C
    Eur J Clin Nutr; 2005 Mar; 59(3):311-7. PubMed ID: 15674316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reproducibility of bone-related biochemical variables in post-menopausal women.
    Morris HA; Wishart JM; Horowitz M; Need AG; Nordin BE
    Ann Clin Biochem; 1990 Nov; 27 ( Pt 6)():562-8. PubMed ID: 2080858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of ethinyl oestradiol on calcium and bone metabolism in peri- and postmenopausal women.
    Marshall RW; Selby PL; Chilvers DC; Hodgkinson A
    Horm Metab Res; 1984 Feb; 16(2):97-9. PubMed ID: 6706290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of calcium restriction on metabolic characteristics of premenopausal women.
    Barger-Lux MJ; Heaney RP
    J Clin Endocrinol Metab; 1993 Jan; 76(1):103-7. PubMed ID: 8421072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting fasting urinary calcium excretion in stone former patients on different dietary calcium intake.
    Messa P; Mioni G; Franzon R; Messa M; Cruciatti A; Giannini S; d'Angelo A
    Scanning Microsc; 1992 Mar; 6(1):239-46. PubMed ID: 1626243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of bone loss by hormone replacement therapy is probably not due to stimulation of calcitonin secretion.
    Fletcher CD; Farish E; Leggate J; Hart DM
    Acta Endocrinol (Copenh); 1991 Apr; 124(4):353-6. PubMed ID: 2031433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic markers for the early diagnosis of postmenopausal osteoporosis.
    Isaia G; Mussetta M; Di Stefano M; Sciolla A; Triolo S; Molinatti GM
    J Endocrinol Invest; 1994 Nov; 17(10):771-4. PubMed ID: 7699209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary citrate, bone resorption and intestinal alkali absorption in stone formers with fasting hypercalciuria.
    Messa P; Mioni G; Paganin L; Cruciatti A; Greco PL; Turrin D
    Scanning Microsc; 1994; 8(3):531-8; discussion 538-9. PubMed ID: 7747155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium chloride supplementation and urinary calcium excretion in postmenopausal women.
    Zarkadas M; Gougeon-Reyburn R; Marliss EB; Block E; Alton-Mackey M
    Am J Clin Nutr; 1989 Nov; 50(5):1088-94. PubMed ID: 2816793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women.
    Vural P; Akgul C; Canbaz M
    Pharmacol Res; 2006 Oct; 54(4):298-302. PubMed ID: 16879975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.